November 11, 2011 — The 30-day results from the 8,500+ patient ADAPT-DES registry were presented at the 2011 TCT ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 9, 2011 – AstraZeneca announced that a combined expert committee of American College of Cardiology Foundation ...
November 9, 2011 — Janssen Pharmaceuticals Inc. announced the U.S. Food and Drug Administration (FDA) has approved ...
October 24, 2011 — A new study demonstrates that angiotensin-converting enzyme (ACE) inhibitors taken in the first ...
October 4, 2011 – Roche announced plans today to expand its coagulation testing product line in North America beyond ...
September 28, 2011 — A clinical trial by Resverlogix Corp. is evaluating the early effects of a new drug compound in ...
September 8, 2011 – A randomized multicenter, open-label study evaluating the efficacy and safety of prolonged ...
September 8, 2011 – Patients at a high risk for a second stroke who received intensive medical treatment had fewer ...
September 6, 2011 — The European Society of Cardiology (ESC) released the latest version of its guidelines for managing ...
August 18, 2011 — The antiplatelet agent prasugrel (trade name Effient), in combination with aspirin, was associated ...
Aug. 2, 2011 — New York University (NYU) Langone Medical Center received an $84 million grant from the National Heart ...
July 21, 2011 – The U.S. Food and Drug Administration (FDA) today approved AstraZeneca’s blood-thinning drug ticagrelor ...
July 5, 2011 — Janssen Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ...
June 14, 2011 – New performance measures for adults with coronary artery disease (CAD) and hypertension were released ...
November 11, 2011